Terms: = Kidney tumors AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2
12 results:
1. Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma.
Narisawa T; Naito S; Ito H; Ichiyanagi O; Sakurai T; Kato T; Tsuchiya N
BMC Cancer; 2023 Feb; 23(1):170. PubMed ID: 36803783
[TBL] [Abstract] [Full Text] [Related]
2. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
[TBL] [Abstract] [Full Text] [Related]
3. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
Roskoski R
Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
[TBL] [Abstract] [Full Text] [Related]
4. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
[TBL] [Abstract] [Full Text] [Related]
5. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
[TBL] [Abstract] [Full Text] [Related]
6. Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children's Oncology Group.
Kieran K; Anderson JR; Dome JS; Ehrlich PF; Ritchey ML; Shamberger RC; Perlman EJ; Green DM; Davidoff AM
J Pediatr Surg; 2013 Jul; 48(7):1598-603. PubMed ID: 23895979
[TBL] [Abstract] [Full Text] [Related]
7. Is there a financial disincentive to perform partial nephrectomy?
Tanagho YS; Figenshau RS; Sandhu GS; Bhayani SB
J Urol; 2012 Jun; 187(6):1995-9. PubMed ID: 22498206
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor.
Lima Lde O; Lerario AM; Alencar GA; Brito LP; Almeida MQ; Domenice S; Latronico AC; Mendonca BB; Fragoso MC
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):72-7. PubMed ID: 21468523
[TBL] [Abstract] [Full Text] [Related]
9. Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.
Schlesinger-Raab A; Treiber U; Zaak D; Hölzel D; Engel J
Eur J Cancer; 2008 Nov; 44(16):2485-95. PubMed ID: 18783939
[TBL] [Abstract] [Full Text] [Related]
10. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
Yu SJ; Zheng L; Ladanyi M; Asa SL; Ezzat S
Clin Cancer Res; 2004 Oct; 10(19):6750-8. PubMed ID: 15475466
[TBL] [Abstract] [Full Text] [Related]
11. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.
Takahashi A; Sasaki H; Kim SJ; Kakizoe T; Miyao N; Sugimura T; Terada M; Tsukamoto T
Biochem Biophys Res Commun; 1999 Apr; 257(3):855-9. PubMed ID: 10208873
[TBL] [Abstract] [Full Text] [Related]
12. Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor.
Ron D; Reich R; Chedid M; Lengel C; Cohen OE; Chan AM; Neufeld G; Miki T; Tronick SR
J Biol Chem; 1993 Mar; 268(8):5388-94. PubMed ID: 7680645
[TBL] [Abstract] [Full Text] [Related]
